Member Info for BeardedDragon

Fund raising imminent for obvious reasons.

Naysayers are usually right I'm afraid to say.

Thursday 12th?

Surely "Site Initiation Visit Successful" would have been better.

Not really sure it's wonderful news. Surely it was inevitable. Maybe the next RNS will tell us that the product has been chemically tested and found to be real gold.

No worries SC, we will hit 8p by Xmas.

We are doomed, Captain Mainwaring.

That must rank as the most stupid post of the year.

Personally I would be very disappointed with only a 5% rise tomorrow.

No because it wasn't tipped in the proper press, merely by some dubious outfit called Telegram.

Please get your facts straight. It was a dodgy media outfit called Telegram rather than the more reputable Telegraph.

Yes, big in the sense of a massive fund raiser or even worse.

Since that 300K purchase at 8.09am Friday, the overwhelming majority of transactions have been sells. The latest being at only 1.25p so hardly encouraging.

If the so-called nut job is suspended from LSE, how come I can still read his posts, which I would not have bothered to do without your posts. You appear frightened by his/her negativity. Personally I like to read both sides of an argument.

No idea what you are talking about. Are you saying ITM is in a good or bad situation?

Do you mean the two massive 77 million sells at 0.115p? They were around 9am Friday so hardly pertinent now.

According to Laura2022 over on the FAB board, Telegram have recommended UK bio pharmaceutical cos for growth in 2025. They list FAB, SCLP, PYC amongst others due to the labour government £1bln+ commitment to UK life science. She can't find the link, sorry. As the SP currently sits near its year low, I will be buying on Monday.

Laura, Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate novel medicines to treat significant unmet needs in cancer. The Company is building a pipeline of innovative products by utilising its four technology platforms: Moditope® and ImmunoBody® for vaccines and GlyMab® and AvidiMab® for antibodies. It seems to be near its year low so may be worth a flutter.

Comfirming what on a Saturday?

Have just bought at 5.24p for my sins. It will probably crash back to 4.75p now.